

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | daunorubicin metabolic process (GO:0044597) | 7.90554610 |
| 2 | polyketide metabolic process (GO:0030638) | 7.90554610 |
| 3 | doxorubicin metabolic process (GO:0044598) | 7.90554610 |
| 4 | maintenance of protein location in nucleus (GO:0051457) | 5.98495067 |
| 5 | histone H4-K5 acetylation (GO:0043981) | 5.38781545 |
| 6 | histone H4-K8 acetylation (GO:0043982) | 5.38781545 |
| 7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.18585267 |
| 8 | histone H4-K12 acetylation (GO:0043983) | 5.18268263 |
| 9 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.13618455 |
| 10 | negative regulation of cell killing (GO:0031342) | 5.13618455 |
| 11 | aminoglycoside antibiotic metabolic process (GO:0030647) | 5.09931568 |
| 12 | somite rostral/caudal axis specification (GO:0032525) | 5.02520188 |
| 13 | regulation of MHC class I biosynthetic process (GO:0045343) | 4.95901613 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.87910584 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.76068624 |
| 16 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.73633452 |
| 17 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.64105290 |
| 18 | muscle organ morphogenesis (GO:0048644) | 4.60321627 |
| 19 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.60034321 |
| 20 | interferon-gamma production (GO:0032609) | 4.59977676 |
| 21 | regulation of response to osmotic stress (GO:0047484) | 4.59743395 |
| 22 | histone H4-K16 acetylation (GO:0043984) | 4.56762926 |
| 23 | negative regulation of G2/M transition of mitotic cell cycle (GO:0010972) | 4.52604630 |
| 24 | positive regulation of histone deacetylation (GO:0031065) | 4.52008306 |
| 25 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.48829709 |
| 26 | pre-miRNA processing (GO:0031054) | 4.48053743 |
| 27 | regulation of telomere maintenance via telomerase (GO:0032210) | 4.43408513 |
| 28 | negative regulation of telomerase activity (GO:0051974) | 4.38209533 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.36289035 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.33428854 |
| 31 | negative thymic T cell selection (GO:0045060) | 4.29169890 |
| 32 | positive thymic T cell selection (GO:0045059) | 4.26108103 |
| 33 | thymic T cell selection (GO:0045061) | 4.23012675 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.22860729 |
| 35 | protein localization to kinetochore (GO:0034501) | 4.22032461 |
| 36 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 4.20213386 |
| 37 | negative regulation of epidermis development (GO:0045683) | 4.16116180 |
| 38 | negative T cell selection (GO:0043383) | 4.14436333 |
| 39 | heterochromatin organization (GO:0070828) | 4.11886378 |
| 40 | positive regulation of protein deacetylation (GO:0090312) | 4.00512983 |
| 41 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.98810289 |
| 42 | negative regulation of cell cycle G2/M phase transition (GO:1902750) | 3.92523522 |
| 43 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.90757059 |
| 44 | nuclear pore complex assembly (GO:0051292) | 3.82457371 |
| 45 | T cell selection (GO:0045058) | 3.81956937 |
| 46 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.79444551 |
| 47 | synaptic vesicle maturation (GO:0016188) | 3.74337442 |
| 48 | positive T cell selection (GO:0043368) | 3.72863826 |
| 49 | retinoic acid receptor signaling pathway (GO:0048384) | 3.62859796 |
| 50 | rRNA transcription (GO:0009303) | 3.60109387 |
| 51 | mannose metabolic process (GO:0006013) | 3.57425970 |
| 52 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.57329307 |
| 53 | hypotonic response (GO:0006971) | 3.57158697 |
| 54 | histone H3-K4 methylation (GO:0051568) | 3.56548300 |
| 55 | NLS-bearing protein import into nucleus (GO:0006607) | 3.54159152 |
| 56 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.54134736 |
| 57 | leukocyte aggregation (GO:0070486) | 3.53477585 |
| 58 | regulation of intracellular estrogen receptor signaling pathway (GO:0033146) | 3.51548692 |
| 59 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 3.51443652 |
| 60 | response to interleukin-15 (GO:0070672) | 3.49517298 |
| 61 | response to dietary excess (GO:0002021) | 3.49267987 |
| 62 | hormone catabolic process (GO:0042447) | 3.45268836 |
| 63 | chromatin assembly (GO:0031497) | 3.45220569 |
| 64 | mitochondrion distribution (GO:0048311) | 3.45218818 |
| 65 | cytidine metabolic process (GO:0046087) | 3.44809335 |
| 66 | cytidine catabolic process (GO:0006216) | 3.44809335 |
| 67 | cytidine deamination (GO:0009972) | 3.44809335 |
| 68 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771) | 3.44761640 |
| 69 | proline transport (GO:0015824) | 3.44149839 |
| 70 | response to muramyl dipeptide (GO:0032495) | 3.43396856 |
| 71 | germinal center formation (GO:0002467) | 3.36497923 |
| 72 | primitive streak formation (GO:0090009) | 3.35529259 |
| 73 | RNA stabilization (GO:0043489) | 3.35393384 |
| 74 | mRNA stabilization (GO:0048255) | 3.35393384 |
| 75 | tolerance induction (GO:0002507) | 3.35256375 |
| 76 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.29248220 |
| 77 | notochord development (GO:0030903) | 3.27417783 |
| 78 | mitotic sister chromatid segregation (GO:0000070) | 3.27205204 |
| 79 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.26629021 |
| 80 | regulation of T cell tolerance induction (GO:0002664) | 3.19096585 |
| 81 | maintenance of protein localization in organelle (GO:0072595) | 3.18571598 |
| 82 | trophectodermal cell differentiation (GO:0001829) | 3.17280295 |
| 83 | T cell migration (GO:0072678) | 3.15901549 |
| 84 | nuclear pore organization (GO:0006999) | 3.11354390 |
| 85 | tachykinin receptor signaling pathway (GO:0007217) | 3.10277003 |
| 86 | establishment of endothelial barrier (GO:0061028) | 3.09019268 |
| 87 | detection of bacterium (GO:0016045) | 3.08860895 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 3.06911409 |
| 89 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 3.06656488 |
| 90 | positive regulation of Rap GTPase activity (GO:0032854) | 3.06539760 |
| 91 | intestinal epithelial cell development (GO:0060576) | 3.05775925 |
| 92 | negative regulation of viral release from host cell (GO:1902187) | 3.04929672 |
| 93 | positive regulation of macrophage cytokine production (GO:0060907) | 3.04556699 |
| 94 | signal complex assembly (GO:0007172) | 3.04073120 |
| 95 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.03691220 |
| 96 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.03691220 |
| 97 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.03691220 |
| 98 | modulation by symbiont of host immune response (GO:0052553) | 3.03691220 |
| 99 | positive regulation by symbiont of host defense response (GO:0052509) | 3.03691220 |
| 100 | modulation by symbiont of host defense response (GO:0052031) | 3.03691220 |
| 101 | maternal placenta development (GO:0001893) | 3.02956391 |
| 102 | negative regulation of T cell mediated immunity (GO:0002710) | 3.00580317 |
| 103 | detection of other organism (GO:0098543) | 3.00468586 |
| 104 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.00121716 |
| 105 | response to type I interferon (GO:0034340) | 2.98098306 |
| 106 | NIK/NF-kappaB signaling (GO:0038061) | 2.94115900 |
| 107 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.93428706 |
| 108 | regulation of ARF protein signal transduction (GO:0032012) | 2.93044985 |
| 109 | negative regulation of epidermal cell differentiation (GO:0045605) | 2.92472417 |
| 110 | cell fate commitment involved in formation of primary germ layer (GO:0060795) | 2.91855198 |
| 111 | cellular response to type I interferon (GO:0071357) | 2.90830979 |
| 112 | type I interferon signaling pathway (GO:0060337) | 2.90830979 |
| 113 | adaptation of signaling pathway (GO:0023058) | 2.90570108 |
| 114 | macrophage activation involved in immune response (GO:0002281) | 2.89112741 |
| 115 | cellular response to interleukin-15 (GO:0071350) | 2.89104758 |
| 116 | protein localization to chromosome, centromeric region (GO:0071459) | 2.88825359 |
| 117 | phenol-containing compound catabolic process (GO:0019336) | 2.88673869 |
| 118 | cardiovascular system development (GO:0072358) | 2.88386101 |
| 119 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.88150410 |
| 120 | sister chromatid segregation (GO:0000819) | 2.87587253 |
| 121 | activated T cell proliferation (GO:0050798) | 2.86696307 |
| 122 | regulation of cilium movement (GO:0003352) | 2.85135035 |
| 123 | response to laminar fluid shear stress (GO:0034616) | 2.84510079 |
| 124 | nucleoside transmembrane transport (GO:1901642) | 2.84240527 |
| 125 | regulation of tolerance induction (GO:0002643) | 2.83503952 |
| 126 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.83273881 |
| 127 | regulation of gene silencing by RNA (GO:0060966) | 2.82042062 |
| 128 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.82042062 |
| 129 | regulation of gene silencing by miRNA (GO:0060964) | 2.82042062 |
| 130 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.81389259 |
| 131 | embryonic placenta development (GO:0001892) | 2.80345326 |
| 132 | negative regulation of telomere maintenance (GO:0032205) | 2.80322422 |
| 133 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.79576514 |
| 134 | regulation of translation in response to stress (GO:0043555) | 2.78860081 |
| 135 | regulation of telomere maintenance (GO:0032204) | 2.78239204 |
| 136 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.78229665 |
| 137 | vitamin A metabolic process (GO:0006776) | 2.77829787 |
| 138 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.77178219 |
| 139 | histone H3-K36 demethylation (GO:0070544) | 2.76437554 |
| 140 | regulation of extracellular matrix disassembly (GO:0010715) | 2.76084269 |
| 141 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.73798539 |
| 142 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.73139565 |
| 143 | regulation of Rap GTPase activity (GO:0032317) | 2.72930848 |
| 144 | regulation of hippo signaling (GO:0035330) | 2.71464586 |
| 145 | regulation of histone H3-K27 methylation (GO:0061085) | 2.70516904 |
| 146 | positive regulation of tolerance induction (GO:0002645) | 2.69019121 |
| 147 | pore complex assembly (GO:0046931) | 2.68084587 |
| 148 | stress granule assembly (GO:0034063) | 2.67730430 |
| 149 | Peyers patch development (GO:0048541) | 2.66899096 |
| 150 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.66899096 |
| 151 | regulation of necroptotic process (GO:0060544) | 2.66646900 |
| 152 | histone H3-K4 trimethylation (GO:0080182) | 2.65432191 |
| 153 | negative regulation of interleukin-2 production (GO:0032703) | 2.65039448 |
| 154 | positive regulation of granulocyte differentiation (GO:0030854) | 2.63117612 |
| 155 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.62128820 |
| 156 | regulation of ARF GTPase activity (GO:0032312) | 2.62091285 |
| 157 | icosanoid secretion (GO:0032309) | 2.61995534 |
| 158 | arachidonic acid secretion (GO:0050482) | 2.61995534 |
| 159 | cellular extravasation (GO:0045123) | 2.61841066 |
| 160 | response to peptidoglycan (GO:0032494) | 2.61629317 |
| 161 | negative regulation of cell size (GO:0045792) | 2.60967776 |
| 162 | natural killer cell differentiation (GO:0001779) | 2.58356992 |
| 163 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.58254034 |
| 164 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.57712432 |
| 165 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.55807640 |
| 166 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.55545743 |
| 167 | negative regulation of interleukin-12 production (GO:0032695) | 2.54659466 |
| 168 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.54315183 |
| 169 | regulation of granulocyte differentiation (GO:0030852) | 2.53962552 |
| 170 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.53907951 |
| 171 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.53907951 |
| 172 | negative regulation of granulocyte differentiation (GO:0030853) | 2.53061266 |
| 173 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.52012329 |
| 174 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.49003539 |
| 175 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.48757960 |
| 176 | negative regulation of innate immune response (GO:0045824) | 2.47583354 |
| 177 | myeloid dendritic cell differentiation (GO:0043011) | 2.46053799 |
| 178 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44816413 |
| 179 | negative regulation of myotube differentiation (GO:0010832) | 2.43835121 |
| 180 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.43683026 |
| 181 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.43678512 |
| 182 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.42723042 |
| 183 | positive regulation of B cell differentiation (GO:0045579) | 2.42606721 |
| 184 | regulation of B cell differentiation (GO:0045577) | 2.42127996 |
| 185 | modulation by symbiont of host cellular process (GO:0044068) | 2.41684386 |
| 186 | detection of external biotic stimulus (GO:0098581) | 2.41350039 |
| 187 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.41218185 |
| 188 | T cell receptor signaling pathway (GO:0050852) | 2.40713275 |
| 189 | negative regulation of type 2 immune response (GO:0002829) | 2.39997753 |
| 190 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.39584860 |
| 191 | regulation of regulatory T cell differentiation (GO:0045589) | 2.36714138 |
| 192 | lymphocyte migration (GO:0072676) | 2.36338822 |
| 193 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.34761425 |
| 194 | modulation by virus of host process (GO:0019054) | 2.34288291 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.80264722 |
| 2 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 5.63468323 |
| 3 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 5.63468323 |
| 4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 5.63468323 |
| 5 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 3.24850846 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.13954953 |
| 7 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 2.72326539 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.67799658 |
| 9 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.56048167 |
| 10 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 2.43619782 |
| 11 | * MYC_22102868_ChIP-Seq_BL_Human | 2.36793785 |
| 12 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.32590138 |
| 13 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.31293183 |
| 14 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.26206088 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.25219355 |
| 16 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 2.18741408 |
| 17 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.13006257 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.12478326 |
| 19 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.12184786 |
| 20 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 2.10813123 |
| 21 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.10056595 |
| 22 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 2.09711793 |
| 23 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 2.04054347 |
| 24 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.02989850 |
| 25 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 2.02973623 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.98102007 |
| 27 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.97892141 |
| 28 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.97248106 |
| 29 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.95661879 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.88747215 |
| 31 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.85853075 |
| 32 | * MAF_26560356_Chip-Seq_TH2_Human | 1.83443108 |
| 33 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.80056166 |
| 34 | * SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.78999542 |
| 35 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.78154407 |
| 36 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.78049549 |
| 37 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.77525366 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75714959 |
| 39 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.74749671 |
| 40 | * ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.74391212 |
| 41 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.74178256 |
| 42 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.74163986 |
| 43 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.70747486 |
| 44 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.66673785 |
| 45 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.66215503 |
| 46 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65528378 |
| 47 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62442326 |
| 48 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.62217291 |
| 49 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.59121913 |
| 50 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.59027555 |
| 51 | * TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.58478850 |
| 52 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.58474195 |
| 53 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.57178399 |
| 54 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.55112602 |
| 55 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54574583 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.53985916 |
| 57 | * MYB_26560356_Chip-Seq_TH2_Human | 1.51787203 |
| 58 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.50908778 |
| 59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.50823081 |
| 60 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.50744061 |
| 61 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.49373812 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47716650 |
| 63 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46898187 |
| 64 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.46479241 |
| 65 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.45521934 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.44380572 |
| 67 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.44195398 |
| 68 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.43210015 |
| 69 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.42148747 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.37767205 |
| 71 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.37673064 |
| 72 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.37478182 |
| 73 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.37225917 |
| 74 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.34687991 |
| 75 | * NANOG_18692474_ChIP-Seq_MESCs_Mouse | 1.32613191 |
| 76 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.31122461 |
| 77 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.30626247 |
| 78 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.28400711 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.27697844 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.26656721 |
| 81 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24637903 |
| 82 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.24473598 |
| 83 | * STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.23992812 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23799465 |
| 85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.23022942 |
| 86 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22768653 |
| 87 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.22629801 |
| 88 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.22128789 |
| 89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21861612 |
| 90 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.21417570 |
| 91 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20612848 |
| 92 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.16644100 |
| 93 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16351001 |
| 94 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.15866091 |
| 95 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.15586905 |
| 96 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.14830289 |
| 97 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14198540 |
| 98 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.12965638 |
| 99 | * POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 1.12104534 |
| 100 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11881126 |
| 101 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.11252946 |
| 102 | * E2F1_17053090_ChIP-ChIP_MCF-7_Human | 1.09483523 |
| 103 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.08553045 |
| 104 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.08443296 |
| 105 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.08244286 |
| 106 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.06632986 |
| 107 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06187215 |
| 108 | P68_20966046_ChIP-Seq_HELA_Human | 1.05730134 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05483716 |
| 110 | * NANOG_16518401_ChIP-PET_MESCs_Mouse | 1.05027684 |
| 111 | SPI1_23127762_ChIP-Seq_K562_Human | 1.04299171 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04110623 |
| 113 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03498039 |
| 114 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.03133303 |
| 115 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.02675398 |
| 116 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02510751 |
| 117 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.02157054 |
| 118 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01877232 |
| 119 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01831852 |
| 120 | * MAF_26560356_Chip-Seq_TH1_Human | 1.01785648 |
| 121 | * SOX2_18692474_ChIP-Seq_MESCs_Mouse | 1.01287114 |
| 122 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.01216031 |
| 123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01082889 |
| 124 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.00882797 |
| 125 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.00781027 |
| 126 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99680741 |
| 127 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99604987 |
| 128 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99045332 |
| 129 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.98950244 |
| 130 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.98572967 |
| 131 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98451388 |
| 132 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97189505 |
| 133 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96893312 |
| 134 | * TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.93844801 |
| 135 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.93428769 |
| 136 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93273091 |
| 137 | * UTX_26944678_Chip-Seq_JUKART_Human | 0.92999647 |
| 138 | * TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.92251470 |
| 139 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92211967 |
| 140 | * POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 0.91922297 |
| 141 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.91873331 |
| 142 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.91533665 |
| 143 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.91447338 |
| 144 | * RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.90185866 |
| 145 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.89627440 |
| 146 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88991941 |
| 147 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.87552804 |
| 148 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.86736689 |
| 149 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.86306236 |
| 150 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.85360228 |
| 151 | * MYB_26560356_Chip-Seq_TH1_Human | 0.81488498 |
| 152 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.81174992 |
| 153 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.80488922 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002254_reproductive_system_inflammat | 4.30540291 |
| 2 | MP0003011_delayed_dark_adaptation | 3.95604674 |
| 3 | MP0004858_abnormal_nervous_system | 3.77921861 |
| 4 | MP0003436_decreased_susceptibility_to | 3.56334603 |
| 5 | MP0004264_abnormal_extraembryonic_tissu | 3.54390581 |
| 6 | MP0008961_abnormal_basal_metabolism | 3.14782164 |
| 7 | MP0003890_abnormal_embryonic-extraembry | 3.11103206 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 3.04883572 |
| 9 | MP0005499_abnormal_olfactory_system | 2.95430629 |
| 10 | MP0005394_taste/olfaction_phenotype | 2.95430629 |
| 11 | MP0002332_abnormal_exercise_endurance | 2.81621879 |
| 12 | MP0006292_abnormal_olfactory_placode | 2.77502219 |
| 13 | MP0001835_abnormal_antigen_presentation | 2.73028444 |
| 14 | MP0010352_gastrointestinal_tract_polyps | 2.64754649 |
| 15 | MP0003724_increased_susceptibility_to | 2.63266467 |
| 16 | MP0005671_abnormal_response_to | 2.56372345 |
| 17 | MP0000685_abnormal_immune_system | 2.43625770 |
| 18 | MP0005000_abnormal_immune_tolerance | 2.41730103 |
| 19 | MP0005025_abnormal_response_to | 2.26257502 |
| 20 | MP0005451_abnormal_body_composition | 2.21493559 |
| 21 | MP0002653_abnormal_ependyma_morphology | 2.16648388 |
| 22 | MP0002723_abnormal_immune_serum | 2.15850345 |
| 23 | MP0003122_maternal_imprinting | 2.12399664 |
| 24 | MP0008057_abnormal_DNA_replication | 2.12107288 |
| 25 | MP0004947_skin_inflammation | 2.11605934 |
| 26 | MP0001873_stomach_inflammation | 2.10946428 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 2.09083733 |
| 28 | MP0005075_abnormal_melanosome_morpholog | 2.08582997 |
| 29 | MP0002419_abnormal_innate_immunity | 2.07485518 |
| 30 | MP0002420_abnormal_adaptive_immunity | 2.07123150 |
| 31 | MP0001819_abnormal_immune_cell | 2.04651856 |
| 32 | MP0002452_abnormal_antigen_presenting | 2.03311994 |
| 33 | MP0010155_abnormal_intestine_physiology | 2.01739012 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.83667706 |
| 35 | MP0009278_abnormal_bone_marrow | 1.79110424 |
| 36 | MP0002398_abnormal_bone_marrow | 1.77881426 |
| 37 | MP0003866_abnormal_defecation | 1.76693324 |
| 38 | MP0002127_abnormal_cardiovascular_syste | 1.74498723 |
| 39 | MP0003121_genomic_imprinting | 1.73439084 |
| 40 | MP0001849_ear_inflammation | 1.72596011 |
| 41 | MP0004381_abnormal_hair_follicle | 1.72253226 |
| 42 | MP0009785_altered_susceptibility_to | 1.70652510 |
| 43 | MP0000716_abnormal_immune_system | 1.69051712 |
| 44 | MP0005257_abnormal_intraocular_pressure | 1.65839671 |
| 45 | MP0005380_embryogenesis_phenotype | 1.65682082 |
| 46 | MP0001672_abnormal_embryogenesis/_devel | 1.65682082 |
| 47 | MP0002933_joint_inflammation | 1.64894390 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.63131564 |
| 49 | MP0002088_abnormal_embryonic_growth/wei | 1.62701035 |
| 50 | MP0003984_embryonic_growth_retardation | 1.60439202 |
| 51 | MP0006082_CNS_inflammation | 1.58053355 |
| 52 | MP0008260_abnormal_autophagy | 1.56911010 |
| 53 | MP0003787_abnormal_imprinting | 1.53552159 |
| 54 | MP0006035_abnormal_mitochondrial_morpho | 1.52067405 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.49460875 |
| 56 | MP0002148_abnormal_hypersensitivity_rea | 1.47524600 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.46578798 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.43533411 |
| 59 | MP0004859_abnormal_synaptic_plasticity | 1.38591061 |
| 60 | MP0003183_abnormal_peptide_metabolism | 1.36917829 |
| 61 | MP0004957_abnormal_blastocyst_morpholog | 1.35453461 |
| 62 | MP0005409_darkened_coat_color | 1.34051731 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.34015958 |
| 64 | MP0002086_abnormal_extraembryonic_tissu | 1.33650638 |
| 65 | MP0000858_altered_metastatic_potential | 1.31905976 |
| 66 | MP0003283_abnormal_digestive_organ | 1.31778732 |
| 67 | MP0002429_abnormal_blood_cell | 1.31634788 |
| 68 | MP0002722_abnormal_immune_system | 1.31483478 |
| 69 | MP0002009_preneoplasia | 1.31184216 |
| 70 | MP0000678_abnormal_parathyroid_gland | 1.28917317 |
| 71 | MP0002277_abnormal_respiratory_mucosa | 1.28439174 |
| 72 | MP0001348_abnormal_lacrimal_gland | 1.27723436 |
| 73 | MP0000689_abnormal_spleen_morphology | 1.26678015 |
| 74 | MP0003690_abnormal_glial_cell | 1.25645990 |
| 75 | MP0001851_eye_inflammation | 1.24572160 |
| 76 | MP0000350_abnormal_cell_proliferation | 1.21157762 |
| 77 | MP0005464_abnormal_platelet_physiology | 1.20450100 |
| 78 | MP0004130_abnormal_muscle_cell | 1.20404695 |
| 79 | MP0003045_fibrosis | 1.18225143 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 1.16845469 |
| 81 | MP0005666_abnormal_adipose_tissue | 1.16343853 |
| 82 | MP0002396_abnormal_hematopoietic_system | 1.15713506 |
| 83 | MP0008770_decreased_survivor_rate | 1.14792229 |
| 84 | MP0005623_abnormal_meninges_morphology | 1.14540543 |
| 85 | MP0001293_anophthalmia | 1.14448162 |
| 86 | MP0003137_abnormal_impulse_conducting | 1.13975987 |
| 87 | MP0009840_abnormal_foam_cell | 1.13539738 |
| 88 | MP0002925_abnormal_cardiovascular_devel | 1.12101504 |
| 89 | MP0002909_abnormal_adrenal_gland | 1.09939371 |
| 90 | MP0002092_abnormal_eye_morphology | 1.09505955 |
| 91 | MP0002084_abnormal_developmental_patter | 1.07556839 |
| 92 | MP0002085_abnormal_embryonic_tissue | 1.06694732 |
| 93 | MP0005076_abnormal_cell_differentiation | 1.06340674 |
| 94 | MP0004043_abnormal_pH_regulation | 1.02724813 |
| 95 | MP0005166_decreased_susceptibility_to | 1.02563200 |
| 96 | MP0003938_abnormal_ear_development | 1.02392711 |
| 97 | MP0008469_abnormal_protein_level | 1.01178060 |
| 98 | MP0004808_abnormal_hematopoietic_stem | 0.99941175 |
| 99 | MP0002269_muscular_atrophy | 0.97511062 |
| 100 | MP0001853_heart_inflammation | 0.95967832 |
| 101 | MP0004197_abnormal_fetal_growth/weight/ | 0.95826779 |
| 102 | MP0003119_abnormal_digestive_system | 0.95084966 |
| 103 | MP0000428_abnormal_craniofacial_morphol | 0.94207382 |
| 104 | MP0003279_aneurysm | 0.91707239 |
| 105 | MP0010630_abnormal_cardiac_muscle | 0.91525456 |
| 106 | MP0005391_vision/eye_phenotype | 0.90421689 |
| 107 | MP0003935_abnormal_craniofacial_develop | 0.89265296 |
| 108 | MP0005253_abnormal_eye_physiology | 0.88403672 |
| 109 | MP0003300_gastrointestinal_ulcer | 0.88375400 |
| 110 | MP0001790_abnormal_immune_system | 0.88321870 |
| 111 | MP0005387_immune_system_phenotype | 0.88321870 |
| 112 | MP0002132_abnormal_respiratory_system | 0.88067853 |
| 113 | MP0002932_abnormal_joint_morphology | 0.87543824 |
| 114 | MP0003075_altered_response_to | 0.87203598 |
| 115 | MP0003448_altered_tumor_morphology | 0.86828983 |
| 116 | MP0000733_abnormal_muscle_development | 0.86801041 |
| 117 | MP0004185_abnormal_adipocyte_glucose | 0.86583872 |
| 118 | MP0000749_muscle_degeneration | 0.86458835 |
| 119 | MP0005310_abnormal_salivary_gland | 0.85884255 |
| 120 | MP0004084_abnormal_cardiac_muscle | 0.85755674 |
| 121 | MP0005248_abnormal_Harderian_gland | 0.85754246 |
| 122 | MP0005375_adipose_tissue_phenotype | 0.85236480 |
| 123 | MP0000750_abnormal_muscle_regeneration | 0.85069936 |
| 124 | MP0002970_abnormal_white_adipose | 0.84782831 |
| 125 | MP0005266_abnormal_metabolism | 0.83633036 |
| 126 | MP0004510_myositis | 0.83623825 |
| 127 | MP0003828_pulmonary_edema | 0.82136732 |
| 128 | MP0003303_peritoneal_inflammation | 0.82130671 |
| 129 | MP0003091_abnormal_cell_migration | 0.81664125 |
| 130 | MP0000249_abnormal_blood_vessel | 0.81480064 |
| 131 | MP0004087_abnormal_muscle_fiber | 0.80975230 |
| 132 | MP0005397_hematopoietic_system_phenotyp | 0.80408381 |
| 133 | MP0001545_abnormal_hematopoietic_system | 0.80408381 |
| 134 | MP0000465_gastrointestinal_hemorrhage | 0.80107164 |
| 135 | MP0000604_amyloidosis | 0.80011400 |
| 136 | MP0001663_abnormal_digestive_system | 0.79935373 |
| 137 | MP0003123_paternal_imprinting | 0.79679215 |
| 138 | MP0005023_abnormal_wound_healing | 0.78042715 |
| 139 | MP0003172_abnormal_lysosome_physiology | 0.77439397 |
| 140 | MP0005167_abnormal_blood-brain_barrier | 0.77034814 |
| 141 | MP0009115_abnormal_fat_cell | 0.76877680 |
| 142 | MP0002006_tumorigenesis | 0.76864215 |
| 143 | MP0005670_abnormal_white_adipose | 0.76740432 |
| 144 | MP0001800_abnormal_humoral_immune | 0.76432601 |
| 145 | MP0002138_abnormal_hepatobiliary_system | 0.76097283 |
| 146 | MP0008874_decreased_physiological_sensi | 0.75008472 |
| 147 | MP0001958_emphysema | 0.74511307 |
| 148 | MP0010030_abnormal_orbit_morphology | 0.74113056 |
| 149 | MP0002877_abnormal_melanocyte_morpholog | 0.74015080 |
| 150 | MP0005390_skeleton_phenotype | 0.73090341 |
| 151 | MP0002114_abnormal_axial_skeleton | 0.73083842 |
| 152 | MP0004883_abnormal_blood_vessel | 0.72943882 |
| 153 | MP0000759_abnormal_skeletal_muscle | 0.72278957 |
| 154 | MP0003566_abnormal_cell_adhesion | 0.71724684 |
| 155 | MP0000432_abnormal_head_morphology | 0.71569610 |
| 156 | MP0002822_catalepsy | 0.71350015 |
| 157 | MP0001730_embryonic_growth_arrest | 0.71171221 |
| 158 | MP0003329_amyloid_beta_deposits | 0.70836762 |
| 159 | MP0009046_muscle_twitch | 0.69204225 |
| 160 | MP0001697_abnormal_embryo_size | 0.69203463 |
| 161 | MP0003763_abnormal_thymus_physiology | 0.68847049 |
| 162 | MP0000313_abnormal_cell_death | 0.68428888 |
| 163 | MP0008789_abnormal_olfactory_epithelium | 0.67664673 |
| 164 | MP0008004_abnormal_stomach_pH | 0.67009912 |
| 165 | MP0003879_abnormal_hair_cell | 0.66970035 |
| 166 | MP0008569_lethality_at_weaning | 0.66825314 |
| 167 | MP0000703_abnormal_thymus_morphology | 0.66693108 |
| 168 | MP0000266_abnormal_heart_morphology | 0.65613949 |
| 169 | MP0002405_respiratory_system_inflammati | 0.64274914 |
| 170 | MP0009703_decreased_birth_body | 0.64100548 |
| 171 | MP0002080_prenatal_lethality | 0.64038224 |
| 172 | MP0004085_abnormal_heartbeat | 0.62579695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Bilateral microphthalmos (HP:0007633) | 6.12337495 |
| 2 | Abnormality of the lower motor neuron (HP:0002366) | 5.35721367 |
| 3 | Hypochromic microcytic anemia (HP:0004840) | 5.10077766 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.73463634 |
| 5 | Hepatoblastoma (HP:0002884) | 4.71987132 |
| 6 | Ependymoma (HP:0002888) | 4.38318922 |
| 7 | Multiple enchondromatosis (HP:0005701) | 4.21359772 |
| 8 | Rib fusion (HP:0000902) | 4.07414347 |
| 9 | Obstructive sleep apnea (HP:0002870) | 3.92090621 |
| 10 | Abnormality of the fingertips (HP:0001211) | 3.80860797 |
| 11 | Neoplasm of striated muscle (HP:0009728) | 3.54282738 |
| 12 | Abnormality of the astrocytes (HP:0100707) | 3.45983501 |
| 13 | Astrocytoma (HP:0009592) | 3.45983501 |
| 14 | Difficulty running (HP:0009046) | 3.27733350 |
| 15 | Myositis (HP:0100614) | 3.17436579 |
| 16 | Increased IgE level (HP:0003212) | 3.17351410 |
| 17 | Pustule (HP:0200039) | 3.07280251 |
| 18 | Colitis (HP:0002583) | 3.06422528 |
| 19 | Testicular atrophy (HP:0000029) | 3.06234847 |
| 20 | Rhabdomyosarcoma (HP:0002859) | 2.98971682 |
| 21 | Abnormality of the salivary glands (HP:0010286) | 2.98769162 |
| 22 | Broad face (HP:0000283) | 2.97233679 |
| 23 | Intestinal fistula (HP:0100819) | 2.97023052 |
| 24 | Amyotrophic lateral sclerosis (HP:0007354) | 2.95827796 |
| 25 | Recurrent fungal infections (HP:0002841) | 2.94045943 |
| 26 | Recurrent bacterial skin infections (HP:0005406) | 2.91307715 |
| 27 | Neoplasm of the heart (HP:0100544) | 2.89147597 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.88170109 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.82878823 |
| 30 | Abnormality of macrophages (HP:0004311) | 2.82153649 |
| 31 | Horizontal nystagmus (HP:0000666) | 2.77433427 |
| 32 | Resting tremor (HP:0002322) | 2.75955018 |
| 33 | Orchitis (HP:0100796) | 2.73941729 |
| 34 | Gastrointestinal inflammation (HP:0004386) | 2.72961759 |
| 35 | Gastrointestinal infarctions (HP:0005244) | 2.70954859 |
| 36 | Meningitis (HP:0001287) | 2.68132451 |
| 37 | Fused cervical vertebrae (HP:0002949) | 2.64934101 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.62710255 |
| 39 | Panhypogammaglobulinemia (HP:0003139) | 2.62143828 |
| 40 | Increased connective tissue (HP:0009025) | 2.61409428 |
| 41 | Generalized hypotonia (HP:0001290) | 2.59631239 |
| 42 | Large earlobe (HP:0009748) | 2.59103294 |
| 43 | Papilledema (HP:0001085) | 2.58125532 |
| 44 | Spontaneous hematomas (HP:0007420) | 2.57864757 |
| 45 | Recurrent viral infections (HP:0004429) | 2.57626070 |
| 46 | Optic neuritis (HP:0100653) | 2.56917193 |
| 47 | Retrobulbar optic neuritis (HP:0100654) | 2.56917193 |
| 48 | Cellulitis (HP:0100658) | 2.56632921 |
| 49 | Short humerus (HP:0005792) | 2.56351411 |
| 50 | Hand muscle atrophy (HP:0009130) | 2.56211682 |
| 51 | Gingivitis (HP:0000230) | 2.55786324 |
| 52 | Rectal fistula (HP:0100590) | 2.54170997 |
| 53 | Rectovaginal fistula (HP:0000143) | 2.54170997 |
| 54 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.52668864 |
| 55 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.51311566 |
| 56 | Cerebral aneurysm (HP:0004944) | 2.49497692 |
| 57 | T lymphocytopenia (HP:0005403) | 2.49242446 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.48889167 |
| 59 | Vasculitis (HP:0002633) | 2.46791668 |
| 60 | Upper limb amyotrophy (HP:0009129) | 2.45640748 |
| 61 | Distal upper limb amyotrophy (HP:0007149) | 2.45640748 |
| 62 | Preauricular skin tag (HP:0000384) | 2.41574379 |
| 63 | Macroorchidism (HP:0000053) | 2.41345698 |
| 64 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.40940496 |
| 65 | Ragged-red muscle fibers (HP:0003200) | 2.40750613 |
| 66 | Skin tags (HP:0010609) | 2.40607149 |
| 67 | Glioma (HP:0009733) | 2.39972142 |
| 68 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.39945328 |
| 69 | Renal duplication (HP:0000075) | 2.38420847 |
| 70 | Gastrointestinal stroma tumor (HP:0100723) | 2.38285351 |
| 71 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.37705185 |
| 72 | Tetraplegia (HP:0002445) | 2.33862223 |
| 73 | Abnormality of chromosome segregation (HP:0002916) | 2.32631229 |
| 74 | Thin bony cortex (HP:0002753) | 2.32393322 |
| 75 | Hemorrhage of the eye (HP:0011885) | 2.32012027 |
| 76 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.31776860 |
| 77 | Periauricular skin pits (HP:0100277) | 2.31395340 |
| 78 | Preauricular pit (HP:0004467) | 2.31395340 |
| 79 | Nasal polyposis (HP:0100582) | 2.31055656 |
| 80 | Pendular nystagmus (HP:0012043) | 2.30368477 |
| 81 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.29841387 |
| 82 | Recurrent cutaneous fungal infections (HP:0011370) | 2.29841387 |
| 83 | Emphysema (HP:0002097) | 2.29795237 |
| 84 | Dysostosis multiplex (HP:0000943) | 2.29786974 |
| 85 | Prolonged bleeding time (HP:0003010) | 2.29082021 |
| 86 | Hypoplasia of the fovea (HP:0007750) | 2.28941933 |
| 87 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.28941933 |
| 88 | Embryonal renal neoplasm (HP:0011794) | 2.28257506 |
| 89 | Abnormality of the musculature of the hand (HP:0001421) | 2.27200872 |
| 90 | Achilles tendon contracture (HP:0001771) | 2.26142698 |
| 91 | Shawl scrotum (HP:0000049) | 2.25218566 |
| 92 | Abnormality of T cell number (HP:0011839) | 2.24109961 |
| 93 | Pseudobulbar signs (HP:0002200) | 2.23886553 |
| 94 | Agammaglobulinemia (HP:0004432) | 2.23237955 |
| 95 | Hypochromic anemia (HP:0001931) | 2.21381755 |
| 96 | Autoimmune thrombocytopenia (HP:0001973) | 2.20591193 |
| 97 | Recurrent skin infections (HP:0001581) | 2.19983285 |
| 98 | Obstructive lung disease (HP:0006536) | 2.19797637 |
| 99 | Chronic obstructive pulmonary disease (HP:0006510) | 2.19797637 |
| 100 | Slow saccadic eye movements (HP:0000514) | 2.17777234 |
| 101 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.16378984 |
| 102 | Hypopigmentation of the fundus (HP:0007894) | 2.16243627 |
| 103 | Vaginal fistula (HP:0004320) | 2.14370842 |
| 104 | Stomatitis (HP:0010280) | 2.14348830 |
| 105 | Partial duplication of thumb phalanx (HP:0009944) | 2.11528220 |
| 106 | Chest pain (HP:0100749) | 2.10948097 |
| 107 | Interstitial pulmonary disease (HP:0006530) | 2.10548288 |
| 108 | Pulmonary infiltrates (HP:0002113) | 2.09651201 |
| 109 | Dyschromatopsia (HP:0007641) | 2.08691336 |
| 110 | Abnormality of the nasal mucosa (HP:0000433) | 2.08179712 |
| 111 | Malignant neoplasm of the central nervous system (HP:0100836) | 2.07909608 |
| 112 | Encephalitis (HP:0002383) | 2.05231188 |
| 113 | Skin pits (HP:0100276) | 2.03833445 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 2.03795222 |
| 115 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.03755795 |
| 116 | Villous atrophy (HP:0011473) | 2.03755795 |
| 117 | Cheilitis (HP:0100825) | 2.03560393 |
| 118 | EMG: neuropathic changes (HP:0003445) | 2.02554254 |
| 119 | Exercise-induced myalgia (HP:0003738) | 2.02272151 |
| 120 | Abnormality of the pubic bones (HP:0003172) | 2.01873110 |
| 121 | Supernumerary ribs (HP:0005815) | 2.01398535 |
| 122 | Malnutrition (HP:0004395) | 2.00226569 |
| 123 | Verrucae (HP:0200043) | 1.98920378 |
| 124 | Papilloma (HP:0012740) | 1.98920378 |
| 125 | Amblyopia (HP:0000646) | 1.98691114 |
| 126 | Easy fatigability (HP:0003388) | 1.98366453 |
| 127 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.97931292 |
| 128 | Hemoptysis (HP:0002105) | 1.97796437 |
| 129 | Mucopolysacchariduria (HP:0008155) | 1.96488674 |
| 130 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96488674 |
| 131 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.96179353 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.96143396 |
| 133 | Vertebral fusion (HP:0002948) | 1.95795752 |
| 134 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.95519623 |
| 135 | Ulnar bowing (HP:0003031) | 1.91547752 |
| 136 | Abnormality of T cells (HP:0002843) | 1.91043332 |
| 137 | Keratoconjunctivitis sicca (HP:0001097) | 1.90875746 |
| 138 | Dislocated radial head (HP:0003083) | 1.90328471 |
| 139 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 1.90193441 |
| 140 | Onion bulb formation (HP:0003383) | 1.89844743 |
| 141 | Restrictive lung disease (HP:0002091) | 1.89493466 |
| 142 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.89219672 |
| 143 | Annular pancreas (HP:0001734) | 1.88527105 |
| 144 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88001471 |
| 145 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88001471 |
| 146 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88001471 |
| 147 | Distal lower limb amyotrophy (HP:0008944) | 1.87202875 |
| 148 | Supernumerary nipples (HP:0002558) | 1.87143485 |
| 149 | Anomalous pulmonary venous return (HP:0010772) | 1.87010577 |
| 150 | Epistaxis (HP:0000421) | 1.86282706 |
| 151 | Absent frontal sinuses (HP:0002688) | 1.86139749 |
| 152 | Uterine leiomyosarcoma (HP:0002891) | 1.85859116 |
| 153 | Leiomyosarcoma (HP:0100243) | 1.85859116 |
| 154 | Flat acetabular roof (HP:0003180) | 1.85086885 |
| 155 | Aneurysm (HP:0002617) | 1.84984576 |
| 156 | Upper motor neuron abnormality (HP:0002127) | 1.84447344 |
| 157 | Asymmetric septal hypertrophy (HP:0001670) | 1.84309798 |
| 158 | Recurrent bronchitis (HP:0002837) | 1.84179649 |
| 159 | Systemic lupus erythematosus (HP:0002725) | 1.83859424 |
| 160 | Febrile seizures (HP:0002373) | 1.83242165 |
| 161 | Polygenic inheritance (HP:0010982) | 1.82991801 |
| 162 | Heterotopia (HP:0002282) | 1.82355317 |
| 163 | Seborrheic dermatitis (HP:0001051) | 1.80780445 |
| 164 | Neoplasm of the oral cavity (HP:0100649) | 1.80768844 |
| 165 | Abnormality of the radial head (HP:0003995) | 1.80182531 |
| 166 | Ureteral stenosis (HP:0000071) | 1.79999068 |
| 167 | Sensory axonal neuropathy (HP:0003390) | 1.79961504 |
| 168 | Granulocytopenia (HP:0001913) | 1.79799630 |
| 169 | Hemiparesis (HP:0001269) | 1.79114118 |
| 170 | Progressive muscle weakness (HP:0003323) | 1.78689999 |
| 171 | Hyperventilation (HP:0002883) | 1.78181998 |
| 172 | Partial duplication of the phalanx of hand (HP:0009999) | 1.78118302 |
| 173 | Lymphopenia (HP:0001888) | 1.77923602 |
| 174 | Combined immunodeficiency (HP:0005387) | 1.77798881 |
| 175 | Neuroectodermal neoplasm (HP:0030061) | 1.76794285 |
| 176 | Neuroepithelial neoplasm (HP:0030063) | 1.76794285 |
| 177 | Nervous tissue neoplasm (HP:0030060) | 1.76794285 |
| 178 | Supranuclear gaze palsy (HP:0000605) | 1.76774631 |
| 179 | Short 5th finger (HP:0009237) | 1.76223992 |
| 180 | Viral hepatitis (HP:0006562) | 1.74842981 |
| 181 | Neuronal loss in central nervous system (HP:0002529) | 1.74723150 |
| 182 | Bifid tongue (HP:0010297) | 1.74630996 |
| 183 | Adenoma sebaceum (HP:0009720) | 1.74422813 |
| 184 | Angiofibromas (HP:0010615) | 1.74422813 |
| 185 | Trismus (HP:0000211) | 1.74383633 |
| 186 | Hyperacusis (HP:0010780) | 1.74284319 |
| 187 | Abnormality of binocular vision (HP:0011514) | 1.73127329 |
| 188 | Diplopia (HP:0000651) | 1.73127329 |
| 189 | Autoimmune hemolytic anemia (HP:0001890) | 1.71985319 |
| 190 | Pulmonary embolism (HP:0002204) | 1.71706891 |
| 191 | Spastic tetraparesis (HP:0001285) | 1.71070002 |
| 192 | Lip pit (HP:0100267) | 1.70852395 |
| 193 | Dysmetric saccades (HP:0000641) | 1.70490262 |
| 194 | Increased cerebral lipofuscin (HP:0011813) | 1.70426396 |
| 195 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.70394588 |
| 196 | Deep venous thrombosis (HP:0002625) | 1.68702841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDK12 | 7.86650898 |
| 2 | GRK5 | 3.93556314 |
| 3 | ERN1 | 3.67064088 |
| 4 | GRK6 | 3.58161085 |
| 5 | TYRO3 | 3.18229514 |
| 6 | GRK1 | 2.48878671 |
| 7 | RIPK4 | 2.44643544 |
| 8 | CSF1R | 2.26857890 |
| 9 | TGFBR2 | 2.20352567 |
| 10 | WNK1 | 2.15730124 |
| 11 | MAPK7 | 2.02567556 |
| 12 | STK10 | 1.97111775 |
| 13 | MAP3K10 | 1.92292277 |
| 14 | ZAP70 | 1.79129844 |
| 15 | ADRBK2 | 1.74320289 |
| 16 | MATK | 1.63596924 |
| 17 | MARK2 | 1.63330096 |
| 18 | FGFR3 | 1.61126074 |
| 19 | SMG1 | 1.58596630 |
| 20 | MAP3K14 | 1.56712519 |
| 21 | GRK7 | 1.56099855 |
| 22 | RIPK1 | 1.52842297 |
| 23 | MAP3K9 | 1.51792794 |
| 24 | ALK | 1.50903302 |
| 25 | CAMK4 | 1.50348849 |
| 26 | SIK2 | 1.47594838 |
| 27 | BLK | 1.46581163 |
| 28 | NTRK1 | 1.43602011 |
| 29 | MAP3K7 | 1.39990766 |
| 30 | IRAK3 | 1.39096017 |
| 31 | MAP2K3 | 1.37981831 |
| 32 | TRIB3 | 1.37537419 |
| 33 | TTK | 1.34635963 |
| 34 | TXK | 1.34060805 |
| 35 | HIPK2 | 1.32960292 |
| 36 | FES | 1.32784555 |
| 37 | IRAK4 | 1.31818796 |
| 38 | MOS | 1.30141085 |
| 39 | BTK | 1.29138477 |
| 40 | SIK3 | 1.25937233 |
| 41 | CAMKK1 | 1.24428792 |
| 42 | IKBKE | 1.19680398 |
| 43 | TBK1 | 1.19494095 |
| 44 | MAP3K3 | 1.18490106 |
| 45 | ICK | 1.15941604 |
| 46 | PRKG2 | 1.08632280 |
| 47 | CSK | 1.06250335 |
| 48 | MAP4K1 | 1.03548929 |
| 49 | TAOK1 | 0.99427037 |
| 50 | MAP2K4 | 0.94864557 |
| 51 | SYK | 0.93804765 |
| 52 | PDGFRA | 0.93605322 |
| 53 | MAP3K1 | 0.91480135 |
| 54 | STK38 | 0.88005611 |
| 55 | LCK | 0.87619415 |
| 56 | MTOR | 0.85600386 |
| 57 | PTK6 | 0.84105101 |
| 58 | TTN | 0.83275022 |
| 59 | MAP3K11 | 0.83160782 |
| 60 | MAPK11 | 0.82378330 |
| 61 | PAK4 | 0.81823438 |
| 62 | CDK7 | 0.81467038 |
| 63 | BMX | 0.80092339 |
| 64 | PAK6 | 0.79229582 |
| 65 | PDPK1 | 0.78675148 |
| 66 | PRKD2 | 0.76013504 |
| 67 | ITK | 0.73226200 |
| 68 | PRKCH | 0.72304985 |
| 69 | RET | 0.71098141 |
| 70 | SIK1 | 0.70519741 |
| 71 | PRKD3 | 0.69581458 |
| 72 | RPS6KC1 | 0.69501098 |
| 73 | RPS6KL1 | 0.69501098 |
| 74 | MAPK12 | 0.68778106 |
| 75 | EPHA2 | 0.67219497 |
| 76 | TAOK2 | 0.66983988 |
| 77 | AKT3 | 0.66414856 |
| 78 | NTRK2 | 0.64033375 |
| 79 | MST1R | 0.63688668 |
| 80 | PKN2 | 0.60451302 |
| 81 | LYN | 0.60275869 |
| 82 | NLK | 0.59337153 |
| 83 | FGR | 0.58785652 |
| 84 | EPHA4 | 0.57909852 |
| 85 | ADRBK1 | 0.57866873 |
| 86 | MAP3K2 | 0.57833285 |
| 87 | KIT | 0.57747682 |
| 88 | CHEK1 | 0.57514404 |
| 89 | RPS6KA6 | 0.57176110 |
| 90 | AKT2 | 0.56108132 |
| 91 | BRD4 | 0.55974086 |
| 92 | MARK3 | 0.54247439 |
| 93 | RPS6KA2 | 0.53994209 |
| 94 | EEF2K | 0.53223219 |
| 95 | PRPF4B | 0.53029584 |
| 96 | TAOK3 | 0.52965364 |
| 97 | MAP3K13 | 0.52864589 |
| 98 | CHEK2 | 0.51175719 |
| 99 | MELK | 0.48475605 |
| 100 | HCK | 0.48148308 |
| 101 | IRAK2 | 0.48134481 |
| 102 | MAP3K6 | 0.47881510 |
| 103 | MAPK10 | 0.47696244 |
| 104 | CAMK1D | 0.46836761 |
| 105 | EPHA3 | 0.46043102 |
| 106 | JAK1 | 0.45460461 |
| 107 | JAK3 | 0.45392613 |
| 108 | PTK2 | 0.44216986 |
| 109 | CDC42BPA | 0.44169479 |
| 110 | CHUK | 0.43924568 |
| 111 | FGFR4 | 0.43908406 |
| 112 | IKBKB | 0.43456477 |
| 113 | DDR2 | 0.43241505 |
| 114 | FYN | 0.42019810 |
| 115 | IRAK1 | 0.41998169 |
| 116 | PDK1 | 0.41852975 |
| 117 | PRKCQ | 0.41535849 |
| 118 | TRPM7 | 0.40676534 |
| 119 | CDK4 | 0.40615741 |
| 120 | JAK2 | 0.40548570 |
| 121 | CAMK1G | 0.40360829 |
| 122 | NTRK3 | 0.40295693 |
| 123 | EPHB1 | 0.39605371 |
| 124 | CDK2 | 0.39496982 |
| 125 | DMPK | 0.39459945 |
| 126 | KSR2 | 0.37322875 |
| 127 | PDGFRB | 0.37303658 |
| 128 | TNK2 | 0.35633665 |
| 129 | DAPK2 | 0.35118059 |
| 130 | INSR | 0.35102259 |
| 131 | PRKAA1 | 0.34259304 |
| 132 | RPS6KA3 | 0.34228231 |
| 133 | STK11 | 0.33070198 |
| 134 | TYK2 | 0.32069765 |
| 135 | GSK3B | 0.30967936 |
| 136 | MAP2K6 | 0.30925736 |
| 137 | NEK2 | 0.30296154 |
| 138 | LATS2 | 0.29987462 |
| 139 | IGF1R | 0.28564705 |
| 140 | CSNK1E | 0.27637628 |
| 141 | ERBB2 | 0.27585249 |
| 142 | SGK3 | 0.27078698 |
| 143 | MAPK1 | 0.26933188 |
| 144 | PRKD1 | 0.26021566 |
| 145 | MAPK14 | 0.25822529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 3.73023576 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.34837946 |
| 3 | mTOR signaling pathway_Homo sapiens_hsa04150 | 2.23341420 |
| 4 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.11781524 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 1.96811309 |
| 6 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.71678020 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.65652502 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 1.63733998 |
| 9 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.55336634 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53720815 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50531024 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.49848832 |
| 13 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.48434712 |
| 14 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.48268933 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.46923409 |
| 16 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.46905877 |
| 17 | Measles_Homo sapiens_hsa05162 | 1.40158352 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37863204 |
| 19 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35775269 |
| 20 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.33875784 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.29910124 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.28581429 |
| 23 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.28523922 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.25172463 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.23681699 |
| 26 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.23511938 |
| 27 | Tuberculosis_Homo sapiens_hsa05152 | 1.22617919 |
| 28 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.21016586 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.18520400 |
| 30 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.17592081 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.17305358 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.16435582 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.15657778 |
| 34 | Galactose metabolism_Homo sapiens_hsa00052 | 1.15408913 |
| 35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.14376002 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.14119524 |
| 37 | Hepatitis C_Homo sapiens_hsa05160 | 1.13602488 |
| 38 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.09981363 |
| 39 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.09951016 |
| 40 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.08915920 |
| 41 | Long-term potentiation_Homo sapiens_hsa04720 | 1.08905870 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.08365091 |
| 43 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.07874065 |
| 44 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06473710 |
| 45 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.05844232 |
| 46 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 1.04833962 |
| 47 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.02932181 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.02787016 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.01089710 |
| 50 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.98217656 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 0.97702419 |
| 52 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.96913511 |
| 53 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.96720407 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.96230784 |
| 55 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.95494873 |
| 56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.95111038 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.94974407 |
| 58 | GABAergic synapse_Homo sapiens_hsa04727 | 0.94619874 |
| 59 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.94589473 |
| 60 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.93296541 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.93005460 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.91832407 |
| 63 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.89769145 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.89435297 |
| 65 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.89434609 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.87367412 |
| 67 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.86798948 |
| 68 | Lysine degradation_Homo sapiens_hsa00310 | 0.86414385 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.85234450 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.85215049 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85076864 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84247391 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.84203154 |
| 74 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.82884133 |
| 75 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82680690 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.82480285 |
| 77 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.81379126 |
| 78 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80932983 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.80417886 |
| 80 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80200707 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.80164289 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.79444613 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.79433271 |
| 84 | Olfactory transduction_Homo sapiens_hsa04740 | 0.79338121 |
| 85 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.78661962 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.78286255 |
| 87 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.78249866 |
| 88 | Pathways in cancer_Homo sapiens_hsa05200 | 0.77661471 |
| 89 | Glioma_Homo sapiens_hsa05214 | 0.77584694 |
| 90 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76366548 |
| 91 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.74859260 |
| 92 | Asthma_Homo sapiens_hsa05310 | 0.74567982 |
| 93 | Renin secretion_Homo sapiens_hsa04924 | 0.72271483 |
| 94 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.72005320 |
| 95 | Prostate cancer_Homo sapiens_hsa05215 | 0.71800278 |
| 96 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71465015 |
| 97 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71392104 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71037088 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69856837 |
| 100 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.69695517 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.69091459 |
| 102 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68622647 |
| 103 | Endocytosis_Homo sapiens_hsa04144 | 0.68190196 |
| 104 | Adherens junction_Homo sapiens_hsa04520 | 0.67935375 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.67496297 |
| 106 | Long-term depression_Homo sapiens_hsa04730 | 0.67356158 |
| 107 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.66821469 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65480606 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.65262982 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64683801 |
| 111 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63969017 |
| 112 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63589117 |
| 113 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62991993 |
| 114 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62224168 |
| 115 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.61714536 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.61470281 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60947452 |
| 118 | Apoptosis_Homo sapiens_hsa04210 | 0.60799255 |
| 119 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60306106 |
| 120 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59938301 |
| 121 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59431841 |
| 122 | Amoebiasis_Homo sapiens_hsa05146 | 0.58790222 |
| 123 | Focal adhesion_Homo sapiens_hsa04510 | 0.58715232 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.58488659 |
| 125 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.58361782 |
| 126 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.58096542 |
| 127 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57663280 |
| 128 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57502207 |
| 129 | Taste transduction_Homo sapiens_hsa04742 | 0.56303538 |
| 130 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55817417 |
| 131 | HTLV-I infection_Homo sapiens_hsa05166 | 0.55808156 |
| 132 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.55734783 |
| 133 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.55118675 |
| 134 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.54512691 |
| 135 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54389778 |
| 136 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54143639 |
| 137 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53728282 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.52439387 |
| 139 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.52431566 |
| 140 | Lysosome_Homo sapiens_hsa04142 | 0.50355175 |

